Oral melphalan, prednisone,thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients

被引：0
|
作者：
Palumbo, A.
Bringhen, S.
Caravita, T.
Falcone, A.
Callea, V.
Cangialosi, C.
Grasso, M.
Galli, M.
Rossini, F.
Catalano, L.
Montanaro, M.
De Stefano, V.
Magarotto, V.
Avonto, I.
Musto, P.
Liberati, A. M.
Cavo, M.
Boccadoro, M.
机构：
[1] Az Osp S Giovanni Battista, Turin, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[4] Osped Riuniti Reggio Calabria, Reggio Di Calabria, Italy
[5] Az Osp Cervello, Palermo, Italy
[6] Az Osp S Croce & Carle, Cuneo, Italy
[7] Osped San Gerardo, Monza, Italy
[8] Univ Naples Federico II, Naples, Italy
[9] Osped S Anna, Ronciglione, Italy
[10] Univ Cattolica, Rome, Italy
[11] Ctr Riferimento Oncol Basilicata, Rionero In Vulture, Italy
[12] Monteluce Policlin, Perugia, Italy
[13] Univ Bologna, Ist Seragnoli, Bologna, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0401
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [21] A RANDOMIZED PHASE II STUDY (GISL-MM03 TRIAL) WITH ORAL MELPHALAN plus PREDNISONE (MP) VERSUS MELPHALAN, plus PREDNISONE plus THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Sacchi, S.
    Marcheselli, R.
    Pozzi, S.
    Bari, A.
    Ciarcia, O.
    Masini, L.
    Lazzaro, A.
    Morabito, F.
    Fragasso, A.
    Di Renzo, N.
    Quarta, G.
    Buda, G.
    Musto, P.
    Vigliotti, M. L.
    Pastorini, A.
    Brugiatelli, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 384 - 384
  • [22] Subcutaneous Bortezomib, Melphalan and Prednisone in Elderly Newly Diagnosed Multiple Myeloma Patients
    Herbaux, Charles
    Joao, Cristina M.
    Plocque, Alexia
    Richez, Valentine
    Gay, Francesca
    Renaud, Loic
    Legros, Laurence
    Garderet, Laurent
    Ikhlef, Souhila
    Pegourie, Brigitte
    Escoffre-Barbe, Martine
    Royer, Bruno
    Voillat, Laurent
    Hulin, Cyrille
    Banos, Anne
    Voog, Eric G.
    Karlin, Lionel
    Stoppa, Anne-Marie
    Benboubker, Lotfi
    Zweegman, Sonja
    De Jongh, Eva
    Abildgaard, Niels
    Le Du, Katell
    Jurczyszyn, Artur J.
    Moreau, Philippe
    Facon, Thierry
    Caillot, Denis
    Terpos, Evangelos
    Leleu, Xavier
    BLOOD, 2014, 124 (21)
  • [23] THALIDOMIDE PLUS MELPHALAN AND PREDNISONE FOR AUSTRALIAN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA IS COST-EFFECTIVE WHEN COMPARED WITH MELPHALAN AND PREDNISONE ALONE
    Lourenco, De Abreu R.
    Colman, S.
    Lee, C.
    VALUE IN HEALTH, 2009, 12 (07) : A381 - A381
  • [24] Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis
    P Kapoor
    S V Rajkumar
    A Dispenzieri
    M A Gertz
    M Q Lacy
    D Dingli
    J R Mikhael
    V Roy
    R A Kyle
    P R Greipp
    S Kumar
    S J Mandrekar
    Leukemia, 2011, 25 : 1523 - 1524
  • [25] ORAL MELPHALAN, PREDNISONE AND THALIDOMIDE IN ELDERLY MULTIPLE MYELOMA PATIENTS: UPDATED RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Palumbo, A.
    Bringhen, S.
    Liberati, A. M.
    Caravita, T.
    Falcone, A.
    Callea, V.
    Cangialosi, C.
    Grasso, M.
    Galli, M.
    Rossini, F.
    Catalano, L.
    De Stefano, V.
    Morandi, S.
    Petrucci, M. T.
    Falco, P.
    Larocca, A.
    Magarotto, V.
    Ciccone, G.
    Cavo, M.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 364 - 365
  • [26] Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
    Palumbo, Antonio
    Bringhen, Sara
    Liberati, Anna M.
    Caravita, Tommaso
    Falcone, Antonietta
    Callea, Vincenzo
    Montanaro, Marco
    Ria, Roberto
    Capaldi, Antonio
    Zambello, Renato
    Benevolo, Giulia
    Derudas, Daniele
    Dore, Fausto
    Cavallo, Federica
    Gay, Francesca
    Falco, Patrizia
    Ciccone, Giovannino
    Musto, Pellegrino
    Cavo, Michele
    Boccadoro, Mario
    BLOOD, 2008, 112 (08) : 3107 - 3114
  • [27] Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
    Waage, Anders
    Gimsing, Peter
    Fayers, Peter
    Abildgaard, Niels
    Ahlberg, Lucia
    Bjorkstrand, Bo
    Carlson, Kristina
    Dahl, Inger Marie
    Forsberg, Karin
    Gulbrandsen, Nina
    Haukas, Einar
    Hjertner, Oyvind
    Hjorth, Martin
    Karlsson, Torbjorn
    Knudsen, Lene Meldgaard
    Nielsen, Johan Lanng
    Linder, Olle
    Mellqvist, Ulf-Henrik
    Nesthus, Ingerid
    Rolke, Jurgen
    Strandberg, Maria
    Sorbo, Jon Hjalmar
    Wisloff, Finn
    Juliusson, Gunnar
    Turesson, Ingemar
    BLOOD, 2010, 116 (09) : 1405 - 1412
  • [28] A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients
    Palumbo, Antonio
    Falco, Patrizia
    Benevolo, Giulia
    Rossi, Davide
    Carella, Angelo Michele
    Guglielmelli, Tommasina
    Rocci, Alberto
    De Paoli, Lorenzo
    Grasso, Mariella
    Siez, Maria Letizia Mosca
    Piro, Eugenio
    Caltagirone, Simona
    Gay, Francesca
    Cavallo, Federica
    Gaidano, Gianluca
    Boccadoro, Mario
    BLOOD, 2010, 116 (21) : 808 - 808
  • [29] Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in TransplantIneligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone
    Hou, Jian
    Fu, Weijun
    Bang, Soo-Mee
    Huang, Honghui
    Kim, Kihyun
    Li, Wei
    An, Gang
    Lee, Je-Jung
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, C. S.
    Rodriguez-Otero, Paula
    Dimopoulos, Meletios A.
    Fujisaki, Tomoaki
    Lee, Jae Hoon
    Wroblewski, Susan
    Carson, Robin
    Qi, Ming
    Wang, Jianping
    Song, Yang
    Bin Jia
    Yang, Xue
    Liu, Wenyu
    Li, Yunan
    Zhang, Renyi
    Wang, Jianxiang
    BLOOD, 2021, 138
  • [30] A prospective randomized trial of oral melphalan, prednisone, thalidomide (MPT) vs oral melphalan, prednisone (MP): An interim analysis.
    Palumbo, A
    Bertola, A
    Musto, P
    Caravita, T
    Callea, V
    Cangialosi, C
    Liberati, AM
    Niscola, P
    Catalano, L
    Grasso, M
    Lauta, VM
    Petti, MC
    Morandi, S
    Galli, M
    Bringhen, S
    Cavallo, F
    Falco, P
    Boccadoro, M
    BLOOD, 2004, 104 (11) : 63A - 63A
12345